Bill & Melinda Gates funding for pharma firm Enesi

Gill Oliver | Pharma | Healthcare | Biotech | Medical | Oct 30th 2019

Milton-Park based pharma company Enesi has won grant funding from the Bill & Melinda Gates Foundation to evaluate its technology platform, which enables the delivery of solid dose vaccines for measles and rubella.

Enesi’s technology is being developed to improve the delivery of vaccines across a wide range of infectious diseases and allergies, and the company is collaborating with several organisations, including Oxford University and Public Health England.

read more...
healthtech

‘That’s the first bit of good news in years,’ says Professor as he welcomes government U-turn on policy allowing graduates to stay longer

Gill Oliver | Healthcare | Biotech | Aerospace | Sep 13th 2019

The government’s recent decision to allow international students to stay in the UK for two years to find a job after graduation is “wonderful”, according to Professor Lionel Tarassenko, head […]

healthtech

Professor Gil McVean takes on full-time CTO role at Genomics

Gill Oliver | Pharma | Healthcare | Biotech | Sep 7th 2019

Data science company Genomics has announced Professor Gil McVean will join on a full-time basis as chief information officer.

healthtech

Nuclear medicine: Concern for patients

Antony David | Pharma | Medical | Aug 23rd 2019

Clinicians, suppliers and The Royal College of Radiologists continue to be concerned about the possible consequences of the UK's departure from the Euratom Treaty. In Oxford University Hospitals NHS Trust, more than 500,000 procedures each year involve ionising radiation. Uncertainty continues around the safeguarding controls and the continuity of supply of radioisotopes caused by the Brexit negotiations and, in particular, the prospect of a no-deal exit at the end of October.

healthtech

Network profile: TheHill digital health community

Antony David | Healthcare | Network profile | Aug 23rd 2019

TheHill is a digital health innovation community, a cluster, network and incubator/accelerator programme working in Oxford with NHS Trusts, universities, digital developers, innovators and investors to catalyse commercial and impactful technological solutions in healthcare. 

healthtech

BOOK REVIEW: Invisible Women by Caroline Criado Perez

Karen David | Book review | Aug 23rd 2019

If you’ve ever wondered why the effects of a prescribed drug were stronger than the doctor promised, why you can’t reach the top shelf in a supermarket, or why you […]

Load More...

Events Coming Soon

12 Nov 2019

Fireside chat on Unconventional Ways of Working at The Wood Centre for Innovation. Panel includes Mike Jennings of Jennings in Garsington, Helen Wright, founder and director of 923 Jobs and Aaron Hirtenstein, member at Agile Collective First. This is the first of a series of fireside chats featuring experts from science and tech. Runs from 1730 to 1930 at The Wood Centre for Innovation, Stansfeld Park, Quarry Road, Headington, OX3 8SB. Details

12 Nov 2019

Cherwell; a thriving economy, a thriving place Cherwell District Council has ambitious plans to create a 10-year strategy to deliver a vibrant, prosperous and sustainable economy for everyone. This workshop is an opportunity to be part of shaping that strategy to create a bright future for the residents, businesses and communities of Cherwell. 5.45 to 9.45pm, RAF Upper Heyford Heritage Centre, Camp Road, Upper Heyford OX25 5HD. Details

13 Nov 2019

Distinguished Speaker Series: Answering the call – Paul Polman, former CEO of Unilever and now Chair of the Saïd Business School Board, is committed to exploring how business education can address the most significant global challenges. Paul was appointed to the U.N. Secretary General’s High-level Panel that developed the Sustainable Development Goals, and has since played a leading role in highlighting the business case for the 2030 development agenda. Paul is Co-founder and Chair of IMAGINE, a benefit corporation and foundation accelerating business leadership to achieve the UN Sustainable Development Goals, and was CEO of Unilever for 10 years, where he demonstrated that a long-term, multi-stakeholder model goes hand-in-hand with good financial performance. During his tenure, Unilever was one of the best-performing companies in its sector, delivering ten years of consistent top and bottom line growth. Pre-talk drinks from 5.30pm, talk 6.45 to 7.45pm. Saïd Business School, Oxford OX1 1HP.  Details

 

See All Events

Subscribe to our newsletter